News Related to Advanced Therapies

Related coverage linked through entity extraction aliases.

CGT Catapult establishes Technology Advisory Board for advanced therapy deployment

May 20, 2026

Cell and Gene Therapy Catapult has established a Technology Advisory Board to support technology deployment across advanced therapies. The board will focus on data, manufacturing, testing and patient pathways.

Origin Genomics Launches Amid Germline Editing Controversy; Thermo Fisher Completes $8.88B Clario Acquisition

Mar 27, 2026

Origin Genomics launches to pursue germline gene editing research despite US prohibitions, while Thermo Fisher completes its $8.88 billion acquisition of Clario Holdings. Lucid Diagnostics reports Q4 revenue growth, and multiple partnerships form across the diagnostics and synthetic biology sectors.